Fe/Ni layered double hydroxide biocatalysts inhibit tumor growth through ROS and ferroptosis signaling pathway
Authors:
- Qiwen PanQPQiwen Pan
- Fei LinFLFei Lin
- Ruiqi LiuRLRuiqi Liu
- Yilin LiYLYilin Li
- Xinyue ZhangXZXinyue Zhang
- Rui LuoRLRui Luo
- Lingling CaiLCLingling Cai
- Yang LiuYLYang Liu
- Wuguo DengWDWuguo Deng
- Liru HeLHLiru He
- 13 April 2023
- journal article
- research article
- Published by Elsevier in Chemical Engineering Journal
- Vol. 466
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81772483, 82102988)
This publication has 56 references indexed in Scilit:
- Functionalized graphene nanocomposites for enhancing photothermal therapy in tumor treatmentAdvanced Drug Delivery Reviews, 2016
- Biological and environmental interactions of emerging two-dimensional nanomaterialsChemical Society Reviews, 2016
- Ferroptosis: process and functionCell Death & Differentiation, 2016
- Amplification of oxidative stress by a dual stimuli-responsive hybrid drug enhances cancer cell deathNature Communications, 2015
- Ferroptosis as a p53-mediated activity during tumour suppressionNature, 2015
- ROS Function in Redox Signaling and Oxidative StressCurrent Biology, 2014
- Microenvironmental regulation of tumor progression and metastasisNature Medicine, 2013
- Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell DeathCell, 2012
- The immune contexture in human tumours: impact on clinical outcomeNature Reviews Cancer, 2012
- Reconciling the chemistry and biology of reactive oxygen speciesNature Chemical Biology, 2008